MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma

Multiple myeloma (MM) patients with the t(14;16) translocation have a poor prognosis, and unlike other molecular subgroups, their outcome has not improved with the introduction of bortezomib (Bzb). The mechanism underlying innate resistance of MM to Bzb is unknown. In the present study, we have inve...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Qiang, Ya-Wei, Ye, Shiqiao, Chen, Yu, Buros, Amy F., Edmonson, Ricky, van Rhee, Frits, Barlogie, Bart, Epstein, Joshua, Morgan, Gareth J., Davies, Faith E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2016
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5179331/
https://ncbi.nlm.nih.gov/pubmed/27793878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-03-706077
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller